Walmart will launch its own brand of insulin, which the retailing giant says will “revolutionize the access and affordability” of diabetes treatments. In a statement Tuesday, Walmart said it will offer analog insulin vials and FlexPens for administering doses through its ReliOn brand. The retailer claims its insulin options will save customers between 58% to 75% compared to branded products. “We know many people with diabetes struggle to manage the financial burden of this condition, and we are focused on helping by providing affordable solutions,” said Dr. Cheryl Pegus, executive vice president, Walmart Health & Wellness, in a statement. The ReliOn products will be available this week at Walmart pharmacies and launch in Sam’s Club pharmacies next month.